Page 42 - Prevnar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A vaccine candidate from Vaxcyte appears to offer better protection against bacterial infections than the Prevnar franchise from Pfizer.

As Pfizer’s new VP and head of the company’s vaccine research and development, Annaliesa Anderson, Ph.D., has a tough act to follow.

NEW YORK CITY (dpa-AFX) - Pharma major Pfizer Inc. (PFE) on Wednesday unveiled positive top-line results from a Phase 3 study, describing the safety and immunogenicity of Prevnar 20, a pneumococcal

United States Vaccines Market Size & Future Development Status 2025 United States vaccines market is set to surpass US$ 21 Billion threshold by 2025. BriefingWire.com, 5/13/2021 - United States vaccines market is set to surpass US$ 21 Billion threshold by 2025. “United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report o...

Vaccine sales power Pfizer through first quarter LINDA A. JOHNSON, AP Medical Writer May 4, 2021 FacebookTwitterEmail 5 1of5FILE - In this April 14, 2021 file photo, a Northwell Health nurse injects Local 28 Sheet Metal Worker Demetrius Buttelman with the first dose of the Pfizer vaccine during a news conference, at the Belmont Park in Elmont, N.Y. The state recorded 43,000 new cases in the week that ended Saturday, April 17, 2021. That's the lowest number in a seven-day period since Thanksgiving.Mary Altaffer/APShow MoreShow Less 2of5Gov. Andrew Cuomo embraces Radhames Rodriguez...